UnitedHealth Group posted second-quarter adjusted earnings that beat analysts’ forecasts and the company raised its earnings outlook for the full year.
“This provides concrete evidence that the [managed care organizations] will likely report 2Q earnings beats largely across the board, given a benign medical cost environment,” wrote Stephens analyst Scott Fidel on Friday.
Fidel reiterated his Overweight rating on the stock and $580 price target.
“The group commands significant commercial market pricing power to manage margins during periods of rising overall inflation,” Fidel wrote.
Cigna, Humana Shares Fall After Report Health-Care Giants Are in Talks to Merge | CNBC